Infertility Treatment Devices and Equipment Market Size, Trends and Growth Analysis by 2027

The market for infertility treatment devices and equipment was valued at approximately US$ 1,050.00 million in 2019 and is projected to grow to US$ 1,973.68 million by 2027, reflecting a compound annual growth rate (CAGR) of 8.4% from 2020 to 2027.

This growth can be primarily attributed to the rising prevalence of infertility among both men and women, alongside an increasing number of fertility clinics and infertility services, bolstered by government initiatives. However, the high costs associated with reproductive procedures pose a significant challenge to market expansion.

Fertility clinics play a crucial role in assisting couples who are struggling to conceive. Many individuals face medical challenges that prevent them from achieving pregnancy naturally. In North America and Europe, numerous fertility clinics and services are available to address infertility issues. Assisted reproductive technology (ART) has become a vital solution, resulting in over 50,000 births annually in the United States, facilitated by approximately 330,000 in vitro fertilization (IVF) procedures. The demand for these services is increasing, particularly among the more than seven million women experiencing infertility, many of whom have postponed childbearing due to career commitments.

In the United States, there are around 450 fertility clinics, over 100 sperm banks, and a significant number of egg donors, along with 1,700 reproductive endocrinologists competing in this sector. Major chains like IntegraMed and Prelude Fertility exist, although most programs are operated by smaller medical practices or are affiliated with hospitals and universities. Various government policies and legal reforms are driving the demand for assisted reproductive procedures in clinics. Notably, around 14 states in the U.S. provide coverage for infertility treatments under medical insurance. In Canada, the government is taking steps to address declining birth rates by sponsoring multiple cycles of artificial insemination and IVF treatments.

The infertility treatment devices and equipment market is categorized by product type into several segments, including ovum aspiration pumps, sperm separation devices, sperm analyzer systems, micromanipulator systems, incubators, and others. The ovum aspiration pumps segment dominated the market in 2019 and is expected to exhibit the highest CAGR during the forecast period.

When categorized by procedure, the market is divided into assisted reproductive technology, artificial insemination, and fertility surgery. The artificial insemination segment held the largest market share in 2019, while the assisted reproductive technology segment is projected to experience the highest growth rate in the coming years.

In terms of end users, the market is segmented into hospitals and other healthcare facilities, fertility centers, and clinical research institutes. The fertility centers segment was the largest market share holder in 2019 and is anticipated to continue growing at a significant rate during the forecast period.

Key regulatory bodies and organizations that have been referenced in the preparation of this report include the Food and Drug Administration (FDA), Centers for Disease Control and Prevention, Canadian Fertility and Andrology Society, Dubai Health Authority, International Committee Monitoring Assisted Reproductive Technologies, and the Indian Society of Assisted Reproduction.